Company profile
Wellcome Sanger Institute
We are a world-leading genomics research institute. Our work helps improve human health and understand life on Earth
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last accounts made up date
Last confirmation statement made up date
Company registered at Companies House
1 Jul 2017 to 30 Jun 2018
The Cambridge Autonomous Bus System Feasibility Study will examine the opportunity to use new, electric, autonomous mini-buses to provide much needed transport links between Cambridge's science campuses, park & ride locations and rail stations. These vehicles and special paths could provide a significant improvement in traffic congestion, improve air qual...
1 Nov 2013 to 31 Oct 2015
We plan to develop a novel, automated cell culture system specifically designed for iPSC and autologous cell culture. Early stage iPS cell culture is very labour intensive since cells must be monitored and fed daily for many weeks. For clinical applications cells must be cultured in a GMP clean room environment, with high staff and infrastructure costs. O...
1 Jan 2011 to 31 Dec 2013
Based in Cambridge, Base4 is developing a single-molecule detector with the capacity for detection of up to 1 billion single molecules per second, thousands of times faster than is otherwise possible. Entirely solid-state, there is a well-worn path towards large scale production and the cost of consumables will be very low. Not reliant on enzymes or patho...
